These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32170033)

  • 1. Randomised trial of azithromycin to eradicate
    Viscardi RM; Terrin ML; Magder LS; Davis NL; Dulkerian SJ; Waites KB; Ambalavanan N; Kaufman DA; Donohue P; Tuttle DJ; Weitkamp JH; Hassan HE; Eddington ND
    Arch Dis Child Fetal Neonatal Ed; 2020 Nov; 105(6):615-622. PubMed ID: 32170033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antenatal azithromycin for Ureaplasma spp. on neonatal outcome at ≤30 weeks' gestational age.
    Kim SH; Chun J; Ko KH; Sung TJ
    Pediatr Int; 2019 Jan; 61(1):58-62. PubMed ID: 30460724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
    Merchan LM; Hassan HE; Terrin ML; Waites KB; Kaufman DA; Ambalavanan N; Donohue P; Dulkerian SJ; Schelonka R; Magder LS; Shukla S; Eddington ND; Viscardi RM
    Antimicrob Agents Chemother; 2015 Jan; 59(1):570-8. PubMed ID: 25385115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomes.
    Viscardi RM; Terrin ML; Magder LS; Davis NL; Dulkerian SJ; Waites KB; Allen M; Ajayi-Akintade A; Ambalavanan N; Kaufman DA; Donohue P; Tuttle DJ; Weitkamp JH
    Pediatr Res; 2022 Jan; 91(1):178-187. PubMed ID: 33658655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial.
    Ballard HO; Shook LA; Bernard P; Anstead MI; Kuhn R; Whitehead V; Grider D; Crawford TN; Hayes D
    Pediatr Pulmonol; 2011 Feb; 46(2):111-8. PubMed ID: 20963840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.
    Viscardi RM; Othman AA; Hassan HE; Eddington ND; Abebe E; Terrin ML; Kaufman DA; Waites KB
    Antimicrob Agents Chemother; 2013 May; 57(5):2127-33. PubMed ID: 23439637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.
    Hassan HE; Othman AA; Eddington ND; Duffy L; Xiao L; Waites KB; Kaufman DA; Fairchild KD; Terrin ML; Viscardi RM
    J Clin Pharmacol; 2011 Sep; 51(9):1264-75. PubMed ID: 21098694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey.
    Pansieri C; Pandolfini C; Elie V; Turner MA; Kotecha S; Jacqz-Aigrain E; Bonati M
    Sci Rep; 2014 Feb; 4():4076. PubMed ID: 24518104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants.
    Lowe J; Gillespie D; Hubbard M; Zhang L; Kirby N; Pickles T; Thomas-Jones E; Turner MA; Klein N; Marchesi JR; Hood K; Berrington J; Kotecha S
    BMJ Open; 2020 Oct; 10(10):e041528. PubMed ID: 33028566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants.
    Ozdemir R; Erdeve O; Dizdar EA; Oguz SS; Uras N; Saygan S; Karabulut E; Dilmen U
    Pediatrics; 2011 Dec; 128(6):e1496-501. PubMed ID: 22123897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Ureaplasma infection pattern and azithromycin treatment effect with bronchopulmonary dysplasia in Ureaplasma positive infants: a cohort study.
    Chen X; Huang X; Lin Y; Lin B; Yang C; Huang Z; Yang C
    BMC Pulm Med; 2023 Jun; 23(1):229. PubMed ID: 37365524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development.
    Turner MA; Jacqz-Aigrain E; Kotecha S
    Arch Dis Child; 2012 Jun; 97(6):573-7. PubMed ID: 21697219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial.
    Lowe J; Gillespie D; Aboklaish A; Lau TMM; Consoli C; Babu M; Goddard M; Hood K; Klein N; Thomas-Jones E; Turner M; Hubbard M; Marchesi J; Berrington J; Kotecha S
    Lancet Respir Med; 2024 Apr; ():. PubMed ID: 38679042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different degrees of maternal Ureaplasma colonization and its correlation with bronchopulmonary dysplasia in <32 weeks' preterm infants.
    Chun J; Chun SH; Han YS; Sung TJ
    Pediatr Neonatol; 2019 Aug; 60(4):441-446. PubMed ID: 30559061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis.
    Nair V; Loganathan P; Soraisham AS
    Neonatology; 2014; 106(4):337-47. PubMed ID: 25278176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.